NCT02505620

Brief Summary

Obstructive Sleep Apnea Syndrome (OSAS) is characterized by repeated episodes of airway obstruction while sleeping. Upper airway obstruction while sleeping leads to a dramatic decrease in oxygen saturation and to hypoxemia finally, in which consequence the patient rapidly awake. Clinical signs are sleepiness and functional cognitive deficits. The Gold standard therapy is "continuous positive airway pressure" ventilation during sleep. However, the success depends strongly to the patient´s compliance. Surgical treatment is an alternative option, which could be considered if clinical success failed. A comparison of the cognitive function of both therapies is not yet analyzed. The study addresses the question which of this treatment options is favorable regarding cognitive function and outcome.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2014

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

June 9, 2015

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 22, 2015

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2016

Completed
Last Updated

December 11, 2020

Status Verified

December 1, 2020

Enrollment Period

2 years

First QC Date

June 9, 2015

Last Update Submit

December 10, 2020

Conditions

Keywords

Neurocognitive functionOSAS

Outcome Measures

Primary Outcomes (1)

  • Neurocognitive function

    Using different tests addressing a various quality of neurocognitive function (attention, memory, perceptual and processing speed, alertness and executive function) participants score test appropriate values. Comparing test values separately allows to distinguish between prior - and post - operative and prior and post - interventional status. Moreover it allows to discriminate achieved test results between both groups and calculate statistical differences. Favorable test results lead to a potential better neurocognitive function outcome and enable to assess neurocognitive function in the light of operation or interventional consequence.

    4 months

Study Arms (2)

Surgical

Surgical correction of OSAS disease

Procedure: Surgical Treatment with multilevel operation

Conservative

Conservative treatment of OSAS disease

Procedure: Treatment of OSAS with CPAP mask

Interventions

Interventional treatment addresses the treatment with a CPAP (continuous positive airway pressure) mask in oder to open patients upper airway obstructive permanently while sleep.

Also known as: CPAP (continuous positive airway pressure) mask
Conservative

Surgical treatment addresses a surgical multilevel anti-obstructive operation in order to eliminate upper airway obstruction permanently.

Also known as: Surgical multilevel anti-obstructive operation
Surgical

Eligibility Criteria

Age30 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients recruted at the University Hospital Erlangen prior surgery or conventional treatment.

You may qualify if:

  • \* Patients within 30 to 70 years of age both gender.

You may not qualify if:

  • Patients under 30 years of age or older than 70 years of age.
  • Preexisting neurological, neuropsychological deficits or diseases, e.g. cerebral insult or epilepsy.
  • Preexisting neurological, neuropsychological medication.
  • Preexisting neuromuscular diseases.
  • Alcohol - and drug abuse.
  • Postoperative complications, pain and time shifts within the test protocol.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Erlangen, Dept. Anaesthesiology

Erlangen, 91054, Germany

Location

MeSH Terms

Interventions

Continuous Positive Airway PressureMasksSurgical Procedures, Operative

Intervention Hierarchy (Ancestors)

Positive-Pressure RespirationRespiration, ArtificialAirway ManagementTherapeuticsRespiratory TherapySurgical AttireEquipment and Supplies, HospitalEquipment and SuppliesProtective DevicesPersonal Protective EquipmentSurgical EquipmentManufactured MaterialsTechnology, Industry, and Agriculture

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 9, 2015

First Posted

July 22, 2015

Study Start

September 1, 2014

Primary Completion

September 1, 2016

Study Completion

September 1, 2016

Last Updated

December 11, 2020

Record last verified: 2020-12

Locations